MONDAY, Feb. 15, 2021 (HealthDay News)– For moms and dads with concerns about COVID-19 vaccines and kids, Johns Hopkins Medication professionals provide responses.
While vaccinations for grownups are underway in the United States, medical trials for the very first U.S. Food and Drug Administration-authorized COVID-19 vaccines have not yet been finished for kids and teenagers more youthful than 16.
Prior to that age can get a vaccine, the FDA and U.S. Centers for Illness Control and Avoidance should accept medical trial results revealing the vaccines are safe and reliable in children, described Dr. Aaron Milstone, a teacher of pediatrics at Hopkins’ School of Medication, and Dr. Kawsar Talaat, assistant teacher at the Bloomberg School of Public Health, in Baltimore.
At this time, Pfizer’s COVID-19 vaccine has FDA approval for usage in individuals 16 and older, while kids aged 12 to 15 have actually been registered in medical trials of the vaccine.
The Moderna vaccine has FDA approval for usage in individuals 18 and older, while kids aged 12 to 17 are being registered in trials of the vaccine.
COVID-19 vaccines for kids older than 12 years might be licensed by late spring or early summer season, however it might be late 2021 or 2022 prior to vaccines are licensed for those more youthful than 12, the physicians stated.
When kids can really get immunized will depend upon the vaccine supply, the professionals kept in mind in a Hopkins press release. Presently, vaccines are being dispersed to groups of individuals based upon concern.
Till children can get immunized, moms and dads need to safeguard their kids from COVID-19 by continuing to practice avoidance procedures, such as using face masks, keeping safe physical range from others and by practicing suitable hand health, Milstone and Talaat encouraged.
The American Academy of Pediatrics has more on COVID-19
SOURCE: Johns Hopkins Medication, press release, Feb. 9, 2021